Pharmaceuticals in North America industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The North American pharmaceuticals market had total revenues of $459.6 billion in 2022, representing a compound annual growth rate (CAGR) of 4.2% between 2017 and 2022.
- 0
- The US acquired an 88.8% share of the North American pharmaceuticals market in 2022. The FDA regulates the pharmaceutical industry in the US, approving 12% of drugs submitted for clinical testing annually. The rigorous clinical trial process results in additional spending on research and development.
Scope
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in North America
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in North America
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the North America pharmaceuticals market with five year forecasts by both value and volume
Reasons to Buy
- What was the size of the North America pharmaceuticals market by value in 2022?
- What will be the size of the North America pharmaceuticals market in 2027?
- What factors are affecting the strength of competition in the North America pharmaceuticals market?
- How has the market performed over the last five years?
- What are the main segments that make up North America's pharmaceuticals market?
Table of Contents
1 Executive Summary
2 Market Overview
3 Market Data
4 Market Segmentation
5 Market Outlook
6 Five Forces Analysis
7 Competitive Landscape
8 Company Profiles
9 Macroeconomic Indicators
10 Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Johnson & Johnson
- Pfizer Inc.
- Merck & Co., Inc.
- AstraZeneca PLC
